On this website
Utility
Appearance
RSS feed
Accessibility
Recently updated Information
Please be advised that we cannot provide any medical information (about drugs, treatments, diagnostics, etc.). You are kindly requested to refer to your doctor or to Telefono Verde AIDS at the Istituto Superiore di Sanità (toll free number from Italy 800 861 061).
About us
Our aim is fighting HIV/AIDS and associated syndromes by developing vaccines and new therapeutic approaches based on studies of the pathogenic mechanisms of HIV infection and progression. The NAC organization reflects the aim to put into effect a “translational” research.
Vaccines against HIV/AIDS
The Tat-based phase II clinical trial “ISS T-002”.
1document
BARBARA ENSOLI WAS APPOINTED AMONG THE NEW MEMBERS OF THE ERC
Barbara Ensoli, Director of the National AIDS Center- ISS, was appointed among the new members of the European Research Council (European Research Council,...
UNRAVELING THE MECHANISMS REQUIRED FOR HIV VACCINE PROTECTION
As published today in PLoS ONE, by binding the Envelope protein present on virus particles, HIV Tat forms a new virus entry complex that favours the infection of cells present at the portals of virus entry (i.e. dendritic cells, macrophages). These cells represent also key HIV reservoirs that ensure the persistence of HIV in the host even under an "effective" antiretroviral treatment. By binding Env, Tat renders ineffective anti-Env antibodies at blocking virus entry in target cells. Thus, both anti-Tat and anti-Env antibodies are...
